Patents by Inventor H. Bud Clark
H. Bud Clark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200405224Abstract: Disclosed are a method and/or system for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. In another embodiment, a method and/or system is directed to automatically determining a maximum interval to alert an attendant following receipt of a measurement at an operator interface. In yet another embodiment, a method and/or system is directed to blood-glucose sensor calibration.Type: ApplicationFiled: July 14, 2020Publication date: December 31, 2020Inventors: Martin Cantwell, H. Bud Clark, Garry M. Steil
-
Patent number: 10722170Abstract: A method and/or system may be provided for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. A method and/or system may also be provided to automatically determine a maximum interval to alert an attendant following receipt of a measurement at an operator interface. A method and/or system may also be provided to blood-glucose sensor calibration.Type: GrantFiled: June 1, 2017Date of Patent: July 28, 2020Assignee: Medtronic Minimed, Inc.Inventors: Martin Cantwell, H. Bud Clark, Garry M. Steil
-
Publication number: 20170325736Abstract: Disclosed are a method and/or system for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. In another embodiment, a method and/or system is directed to automatically determining a maximum interval to alert an attendant following receipt of a measurement at an operator interface. In yet another embodiment, a method and/or system is directed to blood-glucose sensor calibration.Type: ApplicationFiled: June 1, 2017Publication date: November 16, 2017Inventors: Martin Cantwell, H. Bud Clark, Garry M. Steil
-
Patent number: 9687194Abstract: Disclosed are a method and/or system for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. In another embodiment, a method and/or system is directed to automatically determining a maximum interval to alert an attendant following receipt of a measurement at an operator interface. In yet another embodiment, a method and/or system is directed to blood-glucose sensor calibration.Type: GrantFiled: June 17, 2009Date of Patent: June 27, 2017Assignee: Medtronic Minimed, Inc.Inventors: Martin Cantwell, H. Bud Clark, Garry M. Steil
-
Patent number: 9320471Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: GrantFiled: June 21, 2012Date of Patent: April 26, 2016Assignee: Medtronic MiniMed, Inc.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Publication number: 20120259278Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: ApplicationFiled: June 21, 2012Publication date: October 11, 2012Applicant: MEDTRONIC MINIMED, INC.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Patent number: 8226556Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: GrantFiled: May 6, 2009Date of Patent: July 24, 2012Assignee: Medtronic MiniMed, Inc.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Publication number: 20100324382Abstract: Disclosed are a method and/or system for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. In another embodiment, a method and/or system is directed to automatically determining a maximum interval to alert an attendant following receipt of a measurement at an operator interface. In yet another embodiment, a method and/or system is directed to blood-glucose sensor calibration.Type: ApplicationFiled: June 17, 2009Publication date: December 23, 2010Applicant: Medtronic Minimed, Inc.Inventors: Martin Cantwell, H. Bud Clark, Garry M. Steil
-
Publication number: 20090234213Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: ApplicationFiled: May 6, 2009Publication date: September 17, 2009Applicant: MEDTRONIC MINIMED, INC.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Patent number: 7547281Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: GrantFiled: December 30, 2005Date of Patent: June 16, 2009Assignee: Medtronic MiniMed, Inc.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil